Nerve Growth Factor Treatment After Brain Injury Prevents Neuronal Death
The DOI matches its Crossref record; 28 of the 28 references it cites were found in a registry or an index.
Abstract
Cholinergic neuronal degeneration after axotomy has been proposed to be due to the loss of a retrogradely transported neurotrophic factor, possibly nerve growth factor (NGF). To test this hypothesis, NGF was continuously infused into the lateral ventricles of adult rats that had received bilateral lesions of all cholinergic axons projecting from the medial septum to the dorsal hippocampus. After 2 weeks of NGF treatment, identification of cholinergic neurons by the presence of the biosynthetic enzyme choline acetyltransferase revealed a dramatic increase (350%) in the survival of the axotomized septal cholinergic neurons. Thus, NGF or an NGF-like molecule can act as a neurotrophic factor for these neurons.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Later, NGF proved to be involved in neuronal repair and survival (Kromer 1987; Shigeno et al. 1991; Sofroniew et al. 2001; Zhao et al. 2004).”
From Neurotrophic factors and neuroplasticity pathways in the pathophysiology and treatment of depression (2018) · cites this paper as Kromer 1987
Citations
Cites
Central cholinergic pathways in the rat: An overview based on an alternative nomenclature (Ch1–Ch6)
Mesulam, M.-M., Mufson, E. J., Wainer, B. H., & Levey, A. I. (1983) · Neuroscience · doi:10.1016/0306-4522(83)90108-2 · Cited by 2,328
Physiology of nerve growth factor.
Thoenen, H., & Barde, Y. A. (1980) · Physiological Reviews · doi:10.1152/physrev.1980.60.4.1284 · Cited by 1,579
Nerve growth factor promotes survival of septal cholinergic neurons after fimbrial transections
Hefti, F. (1986) · The Journal of Neuroscience · doi:10.1523/jneurosci.06-08-02155.1986 · Cited by 1,450
Levi‐Montalcini, R., & Hamburger, V. (1951) · Journal of Experimental Zoology · doi:10.1002/jez.1401160206 · Cited by 955
Korsching, S., Auburger, G., Heumann, R., Scott, J., & Thoenen, H. (1985) · The EMBO Journal · doi:10.1002/j.1460-2075.1985.tb03791.x · Cited by 938
Gnahn, H., Hefti, F., Heumann, R., Schwab, M. E., & Thoenen, H. (1983) · Developmental Brain Research · doi:10.1016/0165-3806(83)90107-4 · Cited by 719
Amaral, D. G., & Kurz, J. (1985) · Journal of Comparative Neurology · doi:10.1002/cne.902400104 · Cited by 687
Seiler, M., & Schwab, M. E. (1984) · Brain Research · doi:10.1016/0006-8993(84)91338-6 · Cited by 591
Shelton, D. L., & Reichardt, L. F. (1986) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.83.8.2714 · Cited by 528
Hefti, F., Hartikka, J., Eckenstein, F., Gnahn, H., Heumann, R., & Schwab, M. (1985) · Neuroscience · doi:10.1016/0306-4522(85)90163-0 · Cited by 491
Research works printed but not linked: 3
- HEFTI, F, SOCIETY FOR NEUROSCIENCE. ABSTRACTS 11: 660 (1985).
- WILLIAMS, L.R., EXOGENOUS FIBRIN MATRICES IN 15 MM AND 20 MM SILICONE REGENERATION CHAMBERS, ANATOMICAL RECORD 214: A144 (1986).
- WINER, B.J., STATISTICAL PRINCIPL: 310 (1962).
Cited by
Items 501–600 of 934
Qi, J., Ojika, M., & Sakagami, Y. (2004) · Bioorganic & Medicinal Chemistry · doi:10.1016/j.bmc.2004.04.049 · Cited by 32
The regulation of nerve growth factor synthesis and delivery to peripheral neurons
Rush, R., Mayo, R., & Zettler, C. (1995) · Pharmacology & Therapeutics · doi:10.1016/0163-7258(94)00059-c · Cited by 31
Maysinger, D., Herrera‐Marschitz, M., Goiny, M., Ungerstedt, U., & Cuello, A. C. (1992) · Brain Research · doi:10.1016/0006-8993(92)90287-j · Cited by 29
Furukawa, Y., Fukazawa, N., Miyama, Y., HAYASHI, K., & Furukawa, S. (1990) · Biochemical Pharmacology · doi:10.1016/0006-2952(90)90731-y · Cited by 29
Miwa, T., Moriizumi, T., Sakashita, H., Kimura, Y., Donjo, T., & Furukawa, M. (1993) · Neuroscience Letters · doi:10.1016/0304-3940(93)90681-a · Cited by 29
Wieloch, T. W., Bergstedt, K., & Hu, B. R. (1993) · Progress in brain research · doi:10.1016/s0079-6123(08)63266-5 · Cited by 31
Rationale for the Planned Clinical Trials with Nerve Growth Factor in Alzheimer’s Disease
Hefti, F. F., & Schneider, L. S. (1990) · Advances in behavioral biology · doi:10.1007/978-1-4684-5847-3_70 · Cited by 29
Stability of septohippocampal neurons following excitotoxic lesions of the rat hippocampus
Kordower, J. H., Burke, M. A., Roback, J. D., & Wainer, B. H. (1992) · Experimental Neurology · doi:10.1016/0014-4886(92)90105-y · Cited by 31
Isofuranodiene: A neuritogenic compound isolated from wild celery (Smyrnium olusatrum L., Apiaceae)
Mustafa, A. M., Maggi, F., Papa, F., Tilki, E. K., Dikmen, M., & Öztürk, Y. (2015) · Food Chemistry · doi:10.1016/j.foodchem.2015.07.079 · Cited by 29
Young, J. M., Pionk, T., Hiatt, I., Geeck, K., & Smith, J. S. (2015) · Brain Research Bulletin · doi:10.1016/j.brainresbull.2015.04.003 · Cited by 30
Lin, Y., Wan, J., Gao, G., Pan, Y., Ding, S., Fan, Y.-L., Wang, Y., & Jiang, J. (2015) · Biomaterials · doi:10.1016/j.biomaterials.2015.08.010 · Cited by 28
Hippocampal tyrosine kinase A receptors are restricted primarily to presynaptic vesicle clusters
Barker-Gibb, A. L., Dougherty, K. D., Einheber, S., Drake, C. T., & Milner, T. A. (2000) · The Journal of Comparative Neurology · doi:10.1002/1096-9861(20010205)430:2<182::aid-cne1024>3.0.co;2-q · Cited by 28
“These postlesion changes can be prevented by either chronic infusion of NGF or implantation of genetically modified cells producing NGF (Hefti, 1986; Kromer, 1987; Rosenberg et al., 1988; Alderson et al., 1996).”
BackgroundTakahashi, L. K. (1996) · Molecular Neurobiology · doi:10.1007/bf02740624 · Cited by 31
“These degenerative changes, however, are prevented by intracerebroventricular administration of NGF (Hefti, 1986; Williams et al., 1986; Kromer, 1987; Koliatsos et al., 1991).”
BackgroundSurvival, growth and function of damaged cholinergic neurons
Gage, F. H., Tuszynski, M. H., Chen, K. S., Armstrong, D. L., & Buzsáki, G. (1989) · Proceedings of the Fourth International Symposium on Polarization Phenomena in Nuclear Reactions · doi:10.1007/978-3-0348-9138-7_26 · Cited by 28
Microencapsulation of genetically engineered fibroblasts secreting nerve growth factor
Maysinger, D., Piccardo, P., Filipović‐Grčić, J., & Cuello, A. C. (1993) · Neurochemistry International · doi:10.1016/0197-0186(93)90089-n · Cited by 28
Vahlsing, H. L., Hagg, T., Spencer, M., Conner, J. M., Manthorpe, M., & Varon, S. S. (1991) · Brain Research · doi:10.1016/0006-8993(91)90098-g · Cited by 28
Axonal regeneration and limited functional recovery following hippocampal deafferentation
Eagle, K. S., Chalmers, G., Clary, D. O., & Gage, F. H. (1995) · The Journal of Comparative Neurology · doi:10.1002/cne.903630304 · Cited by 28
Hutter, P., Johansson, M. H., Saria, A., & Humpel, C. (1996) · Neuroscience · doi:10.1016/0306-4522(95)00346-k · Cited by 30
Axonal regeneration, growth factors and neuropeptides
Dekker, A. J. A. M., Gispen, W. H., & de Wied, D. (1987) · Life Sciences · doi:10.1016/0024-3205(87)90593-5 · Cited by 30
The Effects of Decompression and Exogenous NGF on Compressed Cerebral Cortex
Chen, J., Wang, Y., & Tseng, G. (2004) · Journal of Neurotrauma · doi:10.1089/0897715042441729 · Cited by 27
NGF protects PC12 cells against ischemia by a mechanism that requires the N‐kinase
Boniece, I. R., & Wagner, J. A. (1995) · Journal of Neuroscience Research · doi:10.1002/jnr.490400102 · Cited by 26
“Intraventricular injection of NGF or FGF in the rat after fimbria-fornix transection has been shown to protect against the loss of cholinergic neurons in the septum and diagonal band (Anderson and Tischler, 1988; Hefti, 1986; Kromer, 1987; Williams et al., 1986).”
BackgroundMarei, H. E. S., Althani, A., Afifi, N. M., Abdelmaksoud, A., Bernardini, C., Michetti, F., Barba, M., Pescatori, M., Maira, G., Paldino, E., et al. (2013) · PLoS ONE · doi:10.1371/journal.pone.0082206 · Cited by 25
“cholinergic neurons in basal forebrain in rats [1–3] and primates [4–7], and phase-I clinical trial of NGF gene therapy”
Potential use of neurotrophic agents in the treatment of neurodegenerative disorders.
Tuszynski, M. H., & Gage, F. H. (1990) · PubMed · Cited by 27
Ito, M., Tsuchida, Y., Mizoue, K., & Hanada, K. (1992) · The Journal of Antibiotics · doi:10.7164/antibiotics.45.1566 · Cited by 27
Effects of Cholinergic Deafferentation and NGF on Brain Electrical Coherence
Holschneider, D. P., Leuchter, A. F., Scremin, O. U., Treiman, D. M., & Walton, N. Y. (1998) · Brain Research Bulletin · doi:10.1016/s0361-9230(97)00446-2 · Cited by 27
“ergic neurons [2,29,31,33,42–44,66,72,73,79] where it protects”
BackgroundChapter 29: The neurotrophic hypothesis and the cholinergic basal forebrain projection
Lucidi‐Phillipi, C. A., & Gage, F. H. (1993) · Progress in brain research · doi:10.1016/s0079-6123(08)62405-x · Cited by 28
Orlowski, C. C., Chernausek, S. D., & Akeson, R. A. (1989) · Journal of Cellular Physiology · doi:10.1002/jcp.1041390304 · Cited by 27
Acute application of NGF increases the firing rate of aged rat basal forebrain neurons
Albeck, D. S., Bäckman, C. M., Veng, L., Friden, P. M., Rose, G. M., & Granholm, A. C. (1999) · European Journal of Neuroscience · doi:10.1046/j.1460-9568.1999.00644.x · Cited by 31
“facilitates behavioural recovery following brain insult or injury (Hefti, 1986; Williams et al., 1986; Kromer, 1987; Dekker et al., 1992; Kordower et al., 1994; Dixon et al., 1997).”
BackgroundInfluentialPeng, Z.-C., Chen, S., Bertini, G., Schmidt, H. H. H. W., & Bentivoglio, M. (1994) · Neuroscience Letters · doi:10.1016/0304-3940(94)90473-1 · Cited by 27
Nerve Growth Factor-Independent Neuronal Survival: A Role for NO Donors
Akassoglou, K. (2005) · Molecular Pharmacology · doi:10.1124/mol.105.017277 · Cited by 26
Ke, X.-J., & Zhang, J. (2013) · Journal of Huazhong University of Science and Technology [Medical Sciences] · doi:10.1007/s11596-013-1137-4 · Cited by 27
Cytosolic Free Calcium and Gene Expression During Chemical Hypoxia
Carroll, J. M., Toral‐Barza, L., & Gibson, G. E. (1992) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.1992.tb11017.x · Cited by 26
Heimrich, B., & Frotscher, M. (1993) · Neuroscience · doi:10.1016/0306-4522(93)90531-j · Cited by 34
Biological Plasticity: The Future of Science in Neurosurgery
Hodge, C. J., & Boakye, M. (2001) · Neurosurgery · doi:10.1097/00006123-200101000-00002 · Cited by 31
Naumann, T., Kermer, P., Seydewitz, V., Ortmann, R., D'Amato, F. R., & Frotscher, M. (1994) · Neuroscience Letters · doi:10.1016/0304-3940(94)90186-4 · Cited by 26
Nerve Growth Factor Systems in Alzheimer’s Disease
Mufson, E. J., & Kordower, J. H. (1999) · Cerebral cortex · doi:10.1007/978-1-4615-4885-0_19 · Cited by 25
Alhaddad, A., Radwan, A., Mohamed, N. A., Mehanna, E. T., Mostafa, Y. M., El-Sayed, N. M., & Fattah, S. A. (2023) · Biomedicines · doi:10.3390/biomedicines11030860 · Cited by 30
“Studies proved that NGF is implicated in neuronal repair and survival [38,39].”
BackgroundThyroxine attenuates hippocampal neuronal damage caused by ischemia in the rat
Rami, A., & Krieglstein, J. (1992) · Life Sciences · doi:10.1016/0024-3205(92)90251-j · Cited by 25
Ito, M., MARUHASHI, M., SAKAI, N., Mizoue, K., & Hanada, K. (1992) · The Journal of Antibiotics · doi:10.7164/antibiotics.45.1559 · Cited by 25
Mielke, R., Kittner, B., Ghaemi, M., Kessler, J., Szelies, B., Herholz, K., & Heiß, W.-D. (1996) · Journal of the Neurological Sciences · doi:10.1016/0022-510x(96)00127-x · Cited by 25
Schinstine, M., Fiore, D. M., Winn, S. R., & Emerich, D. F. (1995) · Cell Transplantation · doi:10.1016/0963-6897(94)00047-n · Cited by 25
Neonatal handling in eae‐susceptible rats altersNGFlevels and mast cell distribution in the brain
Manni, L., Micera, A., Pistillo, L., & Aloe, L. (1998) · International Journal of Developmental Neuroscience · doi:10.1016/s0736-5748(98)00003-3 · Cited by 30
Eagleson, K. L., Cunningham, T. J., & Haun, F. (1992) · Experimental Neurology · doi:10.1016/0014-4886(92)90163-k · Cited by 25
Unsicker, K., & Wiegandt, H. (1988) · Experimental Cell Research · doi:10.1016/0014-4827(88)90407-7 · Cited by 25
Katoh‐Semba, R., Semba, R., Kashiwamata, S., & Kato, K. (1990) · Brain Research · doi:10.1016/0006-8993(90)91584-4 · Cited by 25
Studies related to the use of colchicine as a neurotoxin in the septohippocampal cholinergic system
Ginn, S. R., & Peterson, G. M. (1992) · Brain Research · doi:10.1016/0006-8993(92)91090-2 · Cited by 25
Kordower, J. H., & Fiandaca, M. S. (1990) · The Journal of Comparative Neurology · doi:10.1002/cne.902980406 · Cited by 28
Neurotrophic mechanisms and neuronal degeneration
Sofroniew, M. V., & Cooper, J. D. (1993) · Seminars in Neuroscience · doi:10.1016/s1044-5765(05)80034-x · Cited by 25
Roback, J. D., Diede, S. J., Downen, M., Lee, H. J., Kwon, J. H., Large, T. H., Otten, U., & Wainer, B. H. (1992) · Developmental Brain Research · doi:10.1016/0165-3806(92)90110-i · Cited by 26
Kawaja, M. D., & Gage, F. H. (1991) · The Journal of Comparative Neurology · doi:10.1002/cne.903070313 · Cited by 25
Delivery of neurotrophic factors in the treatment of age-related chronic neurodegenerative diseases
Padmakumar, S., Taha, M. S., Kadakia, E., Bleier, B. S., & Amiji, M. M. (2020) · Expert Opinion on Drug Delivery · doi:10.1080/17425247.2020.1727443 · Cited by 26
“NGF therapy has also displayed tremendous positive results in obliterating cholinergic cell atrophy caused by the disturbance of septo-hippocampal connection in AD rat models [44].”
BackgroundCao, J., Lin, Y., Han, Y., Ding, S., Fan, Y., Pan, Y., Zhao, B., Guo, Q., Sun, W., Wan, J., et al. (2018) · CNS Neuroscience & Therapeutics · doi:10.1111/cns.12818 · Cited by 29
Traditional Chinese medicine-based neurorestorative therapy for Alzheimer’s and Parkinson’s disease
Zhang, Z., Zhang, S., Lui, C. N. P., Zhu, P., Zhang, Z., Lin, K., Dai, Y., & Yung, K. K. L. (2019) · Journal of Neurorestoratology · doi:10.26599/jnr.2019.9040026 · Cited by 26
New Pharmacologic Strategies for Acute Neuronal Injury
Luer, M. S., Rhoney, D. H., Hughes, M. A., & Hatton, J. (1996) · Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy · doi:10.1002/j.1875-9114.1996.tb03000.x · Cited by 24
Drug effects on learning and memory
Vogel, H. G., & Vogel, W. H. (1997) · Springer eBooks · doi:10.1007/978-3-662-03333-3_6 · Cited by 24
Nerve growth factor facilitates conditioned taste aversion learning in normal rats
Lipinski, W. J., Rusiniak, K. W., Hilliard, M., & Davis, R. E. (1995) · Brain Research · doi:10.1016/0006-8993(95)00673-e · Cited by 24
Eriksdotter, M., Skirboll, S. L., Ebendal, T., & Olson, L. (1989) · Neuroscience · doi:10.1016/0306-4522(89)90167-x · Cited by 24
Treatment of Focal Cerebral Ischemia with Liposomal Nerve Growth Factor
Luk, Y.-O., Chen, W. Y.-K., Wong, W.-J., Hu, H., Hsu, L., Chern, C.-M., Huang, K.-J., & Law, S.-L. (2004) · Drug Delivery · doi:10.1080/10717540490494104 · Cited by 23
“…approaches have been developed to facilitate the administration of NGF to the brain such as continuous minipump infusion (Williams et al. 1986; Kromer 1987), microsphere carriers (Mahoney and Saltzman 1996; Lam, Duenas, and Cleland 2001), and polymeric implants (Powell, Sobarzo, and Saltzman…”
BackgroundMethodInfluentialThe treatment of Alzheimer's disease
Allen, N. H. P., & Burns, A. S. (1995) · Journal of Psychopharmacology · doi:10.1177/026988119500900108 · Cited by 26
A Novel Neuritogenic Compound, NGA0187.
Nozawa, Y., SAKAI, N., Matsumoto, K., & Mizoue, K. (2002) · The Journal of Antibiotics · doi:10.7164/antibiotics.55.629 · Cited by 23
Ito, M., SAKAI, N., Ito, K., Mizobe, F., Hanada, K., Mizoue, K., Bhandari, R., Eguchi, T., & Kakinuma, S. (1999) · The Journal of Antibiotics · doi:10.7164/antibiotics.52.224 · Cited by 23
Prakash, N., Cohen‐Cory, S., Penschuck, S., & Frostig, R. D. (2004) · Journal of Neurophysiology · doi:10.1152/jn.00489.2003 · Cited by 24
Colangelo, A. M., Follesa, P., & Mocchetti, I. (1998) · Molecular Brain Research · doi:10.1016/s0169-328x(97)00296-9 · Cited by 23
Enhanced Learning in Mice Parallels Vector-Mediated Nerve Growth Factor Expression in Hippocampus
Brooks, A. I., Cory‐Slechta, D. A., Bowers, W. J., Murg, S. L., & Federoff, H. J. (2000) · Human Gene Therapy · doi:10.1089/104303400750038453 · Cited by 23
“In fore-brain cholinergic neurons NGF signal transduction stimulates the synthesis of the choline acetyltransferase (ChAT), an en-Departments zyme in acetylcholine biosynthesis (Hefti, 1986; Kromer, 1987; Gage et al., 1988; Emerich et al., 1994; Kordower et al., 1994; Winn et al., 1994).”
Chapter 1 Neural plasticity in aging and Alzheimer's disease: some selected comments
Phelps, C. H. (1990) · Progress in brain research · doi:10.1016/s0079-6123(08)63162-3 · Cited by 33
NABESHIMA, T., Ogawa, S., Ishimaru, H., Kameyama, T., Fukuta, T., Takeuchi, R., & HAYASHI, K. (1991) · Biochemical and Biophysical Research Communications · doi:10.1016/s0006-291x(05)81222-7 · Cited by 23
Fuji, K., Hiramatsu, M., Hayashi, S., Kameyama, T., & Nabeshima, T. (1993) · Neuroscience Letters · doi:10.1016/0304-3940(93)90117-4 · Cited by 23
Gibbs, R. B., Chao, M. V., & Pfaff, D. W. (1991) · Molecular Brain Research · doi:10.1016/0169-328x(91)90029-w · Cited by 23
Gene Therapy for Parkinsons and Alzheimers Diseases: from the Bench to Clinical Trials
Nobre, R. J., & de Almeida, L. P. (2011) · Current Pharmaceutical Design · doi:10.2174/138161211798072472 · Cited by 24
“The first studies, based on continuous infusion of exogenous NGF protein into the brain ventricular system, completely prevented the death of cholinergic neurons in the basal forebrain of adult rats [127-129] and adult non-human primates after axotomy [130-132].”
BackgroundOverloading a Muscle Does Not Alter the Rate of Motoneuronal Loss in Aged Rats
Kanda, K., Hashizume, K., Miwa, T., & Miwa, Y. (1996) · Neurobiology of Aging · doi:10.1016/0197-4580(96)00004-8 · Cited by 22
Zhou, X., Herman, J. P., & Paden, C. M. (1999) · Experimental Neurology · doi:10.1006/exnr.1999.7189 · Cited by 22
Urschel, B. A., & Hulsebosch, C. E. (1992) · Brain Research · doi:10.1016/0006-8993(92)91702-g · Cited by 24
Cerebrocortical Microdysgenesis with Anomalous Callosal Connections: A Case Study in the Rat
Rosen, G. D., Galaburda, A. M., & Sherman, G. F. (1989) · International Journal of Neuroscience · doi:10.3109/00207458908987438 · Cited by 22
Depression of Neuronal Protein Synthesis Initiation by Protein Tyrosine Kinase Inhibitors
Hu, B. R., Yang, Y. B. O., & Wieloch, T. W. (1993) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.1993.tb09817.x · Cited by 22
Naumann, T., Straube, A., & Frotscher, M. (1997) · European Journal of Neuroscience · doi:10.1111/j.1460-9568.1997.tb01488.x · Cited by 22
Azmitia, E. C., Whitaker‐Azmitia, P. M., & Bartus, R. T. (1988) · Neurobiology of Aging · doi:10.1016/s0197-4580(88)80142-8 · Cited by 24
Migration of luteinizing hormone?releasing hormone (LHRH) neurons in early human embryos
Schwanzel-Fukuda, M., Crossin, K. L., Pfaff, D. W., Bouloux, P. M. G., Hardelin, J.-P., & Petit, C. (1996) · The Journal of Comparative Neurology · doi:10.1002/(sici)1096-9861(19960311)366:3<547::aid-cne12>3.0.co;2-m · Cited by 170
Acidic Fibroblast Growth Factor Infusion Reduces Ischemic CA1 Hippocampal Damage in the Gerbil
MacMillan, V., Roche, K. W., & Davis, J. M. (1993) · Canadian Journal of Neurological Sciences / Journal Canadien des Sciences Neurologiques · doi:10.1017/s0317167100047375 · Cited by 21
6 Nerve Growth Factor and the Issue of Mitosis in the Nervous System
BLACK, J., DiCicco-Bloom, E. M., & Dreyfus, C. F. (1990) · Current topics in developmental biology/Current Topics in Developmental Biology · doi:10.1016/s0070-2153(08)60087-3 · Cited by 22
Wayne, D. B., & Heaton, M. B. (1990) · Developmental Biology · doi:10.1016/0012-1606(90)90214-4 · Cited by 22
Hollerbach, E. H., Haas, C. A., Hildebrandt, H., Frotscher, M., & Naumann, T. (1998) · The Journal of Comparative Neurology · doi:10.1002/(sici)1096-9861(19980126)390:4<481::aid-cne3>3.0.co;2-x · Cited by 22
Schwaber, J. S., Due, B. E., Rogers, W. T., Junard, E. O., Sharma, A., & Hefti, F. F. (1991) · The Journal of Comparative Neurology · doi:10.1002/cne.903090104 · Cited by 22
Stephens, P. H., Tagari, P. C., & Cuello, A. C. (1988) · Brain Research · doi:10.1016/0006-8993(88)91270-x · Cited by 22
Rockenstein, E. M., Ubhi, K. K., Pham, E., Michael, S. A., Doppler, E., Novak, P. H., Inglis, C. A., Mante, M., Adame, A., Alvarez, X. A., et al. (2011) · Journal of Neuroscience Research · doi:10.1002/jnr.22712 · Cited by 21
Cortical peroxynitration of nerve growth factor in aged and cognitively impaired rats
Bruno, M. A., & Cuello, A. C. (2011) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2011.09.031 · Cited by 21
“In addition, administration of xogenous NGF into the brain leads to a significant increase n the level and activity of ChAT (Garofalo and Cuello, 994; Hefti, 1986; Kromer, 1987; Mobley et al., 1985; illiams and Rylett, 1990) ameliorating learning deficits in ged rats (Bäckman et al.”
BackgroundMarczynski, T. J. (1995) · Reviews in the Neurosciences · doi:10.1515/revneuro.1995.6.3.221 · Cited by 21
Emmett, C. J., Aswani, S. P., Stewart, G. R., Fairchild, D., & Johnson, R. M. (1995) · Brain Research · doi:10.1016/0006-8993(94)01414-d · Cited by 21
Motor Neuron Involvement in Experimental Lumbar Nerve Root Compression
Kobayashi, S., Uchida, K., Yayama, T., Takeno, K., Miyazaki, T., Shimada, S., Kubota, M., Nomura, E., Meir, A. R., & Baba, H. (2007) · Spine · doi:10.1097/01.brs.0000257559.84494.15 · Cited by 21
Friedman, W. (2005) · Molecular Neurobiology · doi:10.1385/mn:32:2:133 · Cited by 21
Gene therapy for neurological disease
Tuszynski, M. H. (2003) · Expert Opinion on Biological Therapy · doi:10.1517/14712598.3.5.815 · Cited by 23
“In rodent and primate studies documenting protection of cholinergic neurons, NGF was infused into the ventricular system of the brain where it diffused short distances to reach cholinergic cell bodies [21-23,38].”
Trophic Factor Effects on Septal Cholinergic Neuronsa
Svendsen, C. N., Cooper, J. D., & Sofroniew, M. V. (1991) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.1991.tb00197.x · Cited by 25
“In addition, NGF is also able to prevent axotomy-induced cell degeneration of septal cholinergic neurons of the basal forebrain following fimbria/fornix lesions when applied exogenously (Hefti 1986; Williams et al. 1986; Kromer 1987).”
MethodShould Intracerebroventricular Nerve Growth Factor Be Used to Treat Alzheimer's Disease?
Saffran, B. N. (1992) · Perspectives in biology and medicine · doi:10.1353/pbm.1992.0055 · Cited by 20
Ligands for EPH‐related tyrosine kinase receptors are developmentally regulated in the CNS
Carpenter, M. K., Shilling, H. G., VandenBos, T., Beckmann, M. P., Cerretti, D. P., Kott, J. N., Westrum, L. E., Davison, B. L., & Fletcher, F. (1995) · Journal of Neuroscience Research · doi:10.1002/jnr.490420207 · Cited by 25
“, 1990); and nerve growth factor (NGF) prevents retrograde degeneration of axotomized septa1 acetylcholine neurons (Hefti, 1986; Williams et al., 1986; Kromer, 1987).”
BackgroundMacklis, J., & Madison, R. (1991) · Journal of Neuroscience · doi:10.1523/jneurosci.11-07-02055.1991 · Cited by 21
“Possible effects of grafting include surgical lesions to antagonist systems from the grafting procedure itself, introduction of trophic factors within the graft, activation of endogenous trophic factors within the host, and breakdown of the blood-brain barrier (Freed, 1983; Gage et al., 1984b; Nietro-Sampedro et al.,…”
BackgroundAxonal regeneration of identified septohippocampal projection neuronsin vitro
Linke, R., Heimrich, B., & Frotscher, M. (1995) · Neuroscience · doi:10.1016/0306-4522(95)00174-h · Cited by 21
Arimatsu, Y., Miyamoto, M., Tsukui, H., & Hatanaka, H. (1989) · Developmental Brain Research · doi:10.1016/0165-3806(89)90048-5 · Cited by 21
Biomaterial approaches to gene therapies for neurodegenerative disorders of the CNS
Newland, B., Dowd, E., & Pandit, A. S. (2013) · Biomaterials Science · doi:10.1039/c3bm60030k · Cited by 22
Triaca, V., Fico, E., Sposato, V., Caioli, S., Ciotti, M. T., Zona, C., Mercanti, D., Mendola, D. L., Satriano, C., Rizzarelli, E., et al. (2020) · Biomolecules · doi:10.3390/biom10020216 · Cited by 21
Capsoni, S., & Cattaneo, A. (2022) · Frontiers in Neuroscience · doi:10.3389/fnins.2022.773347 · Cited by 21
“Most importantly, NGF is able to prevent BFCN death or atrophy, following axotomy (Hefti, 1986; Williams et al., 1986; Kromer, 1987) or linked to aging (Fischer et al., 1987).”
BackgroundDasgupta, S., Montroull, L. E., Pandya, M. A., Zanin, J. P., Wang, W., Wu, Z., & Friedman, W. (2023) · eNeuro · doi:10.1523/eneuro.0067-23.2023 · Cited by 24
“Mature NTs promote a prosurvival response through Trk signaling (Alderson et al., 1990; Hefti et al., 1985; Friedman et al., 1993; Kromer, 1987), whereas proneurotrophins (proNTs) bind p75NTR and sortilin to promote apoptosis in BFCNs (Volosin et al.”
Background
Metadata
- Authors
- Kromer, L. F.
- Affiliations
- Georgetown University (US)
- Corresponding author
- Kromer, Lawrence F.
- Venue
- Science
- Published
- 1987-01-09
- Volume
- 235
- Issue
- 4785
- Pages
- 214-216
- ISSN
- 0036-8075 (ISSN-L)
- 1095-9203
- OpenAlex
- W2069095254
- Cited by
- 932
- References
- 28
- Citations by year
- 2025: 3 · 2024: 8 · 2023: 4 · 2022: 5 · 2021: 8 · 2020: 6 · 2019: 9 · 2018: 10 · 2017: 7 · 2016: 6 · 2015: 14 · 2014: 3 · 2013: 11 · 2012: 6
- FWCI
- 31.51
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Science (publishedVersion)
- PubMed (publishedVersion)
- Funders
- National Institute on Aging (AG-06648)
- Topics
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Nerve injury and regeneration
- Life Sciences › Neuroscience › Developmental Neuroscience › Neurogenesis and neuroplasticity mechanisms
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Nuclear Receptors and Signaling
- Keywords
- nerve growth factor, neurotrophic factors, axotomy, cholinergic neurons, neuronal survival, medial septum, dorsal hippocampus, choline acetyltransferase, brain injury, neuroprotection, retrograde transport
- MeSH terms
- Animals, Brain Injuries, Cell Survival, Choline O-Acetyltransferase, Cholinergic Fibers, Female, Hippocampus, Nerve Growth Factors, Neurons, Rats, Inbred Strains, Septum Pellucidum, Rats
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.